Victory Capital Management’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
Other funds holding ASMB
AC
AIM
BBA
BC
CS
PIM
SCM
Victory Capital Management's ASMB Position: Q1 2021 in Review
Victory Capital Management sold out of Assembly Biosciences (ASMB) in Q1 2021, closing a stake of 2,476 shares — an estimated $180K sold.
Victory Capital Management first reported a position in ASMB in Q1 2017 and held it in 15 quarters. The position peaked at $38.7M in Q1 2020. 107 funds tracked by Wall St. Rank hold ASMB as of Q1 2021.
- Victory Capital Management reported no remaining Assembly Biosciences position as of Q1 2021 after selling out during the quarter.
- Victory Capital Management sold 2,476 Assembly Biosciences shares in Q1 2021, an estimated $180K.
- Victory Capital Management first reported a position in Assembly Biosciences in Q1 2017 and held it in 15 quarters.
- Victory Capital Management's Assembly Biosciences position peaked at $38.7M in Q1 2020.
- 107 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2021.
Based on Victory Capital Management's 13F filing for Q1 2021, filed 4 May 2021.